![Nicholas H. Vetter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Nicholas H. Vetter
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OncoBeta GmbH
![]() OncoBeta GmbH Medical SpecialtiesHealth Technology OncoBeta GmbH is a privately held medical device company based in Garching near Munich, Germany. The German company specializes in the development and commercialization of innovative therapies, particularly the epidermal radioisotope therapy Rhenium-SCT® for non-melanoma skin cancers and keloid scars. OncoBeta was founded in 2010 by Oliver Buck and Doris Zur Muehlen, and the CEO is Shannon D. Brown. | Operationeel Directeur | - | - |
Loopbaan van Nicholas H. Vetter
Statistieken
Internationaal
Duitsland | 2 |
Operationeel
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
OncoBeta GmbH
![]() OncoBeta GmbH Medical SpecialtiesHealth Technology OncoBeta GmbH is a privately held medical device company based in Garching near Munich, Germany. The German company specializes in the development and commercialization of innovative therapies, particularly the epidermal radioisotope therapy Rhenium-SCT® for non-melanoma skin cancers and keloid scars. OncoBeta was founded in 2010 by Oliver Buck and Doris Zur Muehlen, and the CEO is Shannon D. Brown. | Health Technology |
- Beurs
- Insiders
- Nicholas H. Vetter
- Ervaring